XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 105 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $372 | -62.7% | 200 | -50.0% | 0.00% | – |
Q2 2023 | $996 | +111.0% | 400 | +100.0% | 0.00% | – |
Q1 2023 | $472 | +47100.0% | 200 | 0.0% | 0.00% | – |
Q4 2022 | $1 | -99.9% | 200 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -50.0% | 200 | -50.0% | 0.00% | – |
Q1 2022 | $2,000 | +100.0% | 400 | +100.0% | 0.00% | – |
Q4 2021 | $1,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,641,920 | $10,493,971 | 39.87% |
Stonepine Capital Management, LLC | 5,915,372 | $11,002,592 | 3.66% |
MPM BioImpact LLC | 3,987,967 | $7,417,619 | 1.98% |
SINECERA CAPITAL, LLC | 253,101 | $470,768 | 0.63% |
Opaleye Management Inc. | 390,000 | $725,400 | 0.24% |
Alpine Global Management, LLC | 300,000 | $558,000 | 0.14% |
DELTEC ASSET MANAGEMENT LLC | 315,246 | $586,358 | 0.13% |
Redmile Group, LLC | 1,046,587 | $1,946,652 | 0.09% |
GSA CAPITAL PARTNERS LLP | 381,231 | $709 | 0.06% |
Soleus Capital Management, L.P. | 304,083 | $565,594 | 0.05% |